Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia — the role of Bcl-2 family dysregulation

This publication has 16 references indexed in Scilit:

• Chlorambucil resistance in B‐cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl‐2‐expressing subclones
  British Journal of Haematology, 1999
• Bax directly induces release of cytochrome c from isolated mitochondria
  Proceedings of the National Academy of Sciences, 1998
• Bcl-2 expression causes redistribution of glutathione to the nucleus
  Proceedings of the National Academy of Sciences, 1998
• Bcl-2 inhibits p53 nuclear import following DNA damage
  Oncogene, 1997
• P53, MDM-2, BAX and BCL-2 and Drug Resistance in Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma, 1997
• REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIA
  British Journal of Haematology, 1996
• Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
  Cytometry, 1996
• Bcl-2,Bax andp53 expression in B-CLL in relation toin vitro survival and clinical progression
  International Journal of Cancer, 1996
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
  Cell, 1993
• Apoptotic Cell Death in Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma, 1993